This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
European Biotech Acquisition Balans Gezondheid
Financiële gezondheid criteriumcontroles 3/6
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
US$0
Schuld
| Rente dekkingsratio | n/a |
| Contant | US$272.63k |
| Aandelen | -US$6.04m |
| Totaal verplichtingen | US$134.75m |
| Totaal activa | US$128.70m |
Recente financiële gezondheidsupdates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: EBAC has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Langlopende schulden: EBAC has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: EBAC is debt free.
Schuld verminderen: EBAC's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Schuldendekking: EBAC has no debt, therefore it does not need to be covered by operating cash flow.
Rentedekking: EBAC has no debt, therefore coverage of interest payments is not a concern.